Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse

International Journal of Radiation Biology

Volumn 86, Issue 6, 2010, Pages 436-444

  Thomas, David M ^a   Fox, Jessica ^a   Haston, Christina K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alveolitis; Imatinib; Lung; Mast cell; Murine models; Radiation

Indexed keywords

IMATINIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; INBRED STRAIN; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG FIBROSIS; MAST CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RESPIRATORY DISTRESS; STRAIN DIFFERENCE; SURVIVAL TIME;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; LUNG; LUNG DISEASES; MAST CELLS; MICE; PIPERAZINES; PLATELET-DERIVED GROWTH FACTOR; PYRIMIDINES; RADIATION DOSAGE; RADIATION INJURIES, EXPERIMENTAL;

MURINAE; MUS;

EID: 77952517567     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553001003674863     Document Type: Article

References (45)

1. Abdollahi A, Li ML, Ping G, Domhan S, Kiessling F, Lee LB, McMahon G, Gröne HJ, Lipson KE, Huber PE. 2005. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. Journal of Experimental Medicine 201:925-935.
2. Adawi A, Zhang Y, Baggs R Rubin P, Williams J, Finkelstein J, Phipps RP. 1998. Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. Clinical Immunology and Immunopathology 89:222-230.
3. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S. 2005. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. American Journal of Respiratory and Critical Care Medicine 171:1279-1285.
4. Appel S, Boehmler AM, Grunebach F, Müller MR, Rupf A, Weck MM, Hartmann U, Reichardt VL, Kanz L, Brümmendorf TH, Brossart P. 2004. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood 103:538-544.
5. Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, Martel-Lafay I, Ginestet C, Alberti L, Nosov D, Etienne-Mastroianni B, Cottin V, Perol M, Guerin JC, Cordier JF, Carrie C. 2005. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. Journal of Clinical Oncology 23:8748-8756.
6. Chaudhary NI, Schnapp A, Park JE. 2006. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. American Journal of Respiratory and Critical Care Medicine 173:769-776.
7. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P. 2002. Radiation pneumonitis and early circulatory cytokine markers. Seminars in Radiation Oncology 12:26-33.
8. Chiang CS, Liu WC, Jung SM, Chen FH, Wu CR, McBride WH, Lee CC, Hong JH. 2005. Compartmental responses after thoracic irradiation of mice: strain differences. International Journal of Radiation Oncology Biology Physics 62:862-871.
9. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB. 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycinmediated lung fibrosis. Journal of Clinical Investigation 114:1308-1316.
10. Diegelmann RF, Evans MC. 2004. Wound healing: an overview of acute, fibrotic and delayed healing. Frontiers in Bioscience 9:283-289.
11. Gleixner KV, Rebuzzi L, Mayerhofer M, Gruze A, Hadzijusufovic E, Sonneck K, Vales A, Kneidinger M, Samorapoompichit P, Thaiwong T, Pickl WF, Yuzbasiyan-Gurkan V, Sillaber C, Willmann M, Valent P. 2007. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells. Experimental Hematology 35:1510-1521.
12. Haiping Z, Takayama K, Uchino J, Harada A, Adachi Y, Kura S, Caicun Z, Tsuzuki T, Nakanishi Y. 2006. Prevention of radiation-induced pneumonitis by recombinant adenovirus mediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Therapy 13:864-872.
13. Haston CK, Amos CI, King TM, Travis, EL. 1996. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Research 56:2596-2601.
14. Haston CK, Begin M, Dorion G and Cory SM. 2007. Distinct loci influence radiation-induced alveolitis from fibrosing alveolitis in the mouse. Cancer Research 67:10796-10803.
15. Haston CK, Travis EL. 1997. Murine susceptibility to radiationinduced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Research 57:5286-5291.
16. Heinzelmann F, Jendrossek V, Lauber K, Nowak K, Eldh T, Boras R, Handrick R, Henkel M, Martin C, Uhlig S, Köhler D, Eltzschig HK, Wehrmann M, Budach W, Belka C. 2006. Irradiation-induced pneumonitis mediated by the CD95/CD95-ligand system. Journal of the National Cancer Institute 98:1248-1251.
17. Hong JH, Jung SM, Tsao TC, Wu CJ, Lee CY, Chen FH, Hsu CH, McBride WH, Chiang CS. 2003. Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury. International Journal of Radiation Biology 79:159-167.
18. Johnston CJ, Williams JP, Elder A, Hernady E, Finkelstein JN. 2004. Inflammatory cell recruitment following thoracic irradiation. Experimental Lung Research 30:369-382.
19. Kong FM, Haken RT, Eisbruch A, Lawrence TS. 2005. Nonsmall cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Seminars in Oncology 32:42-54.
20. Krishnaswamy G, Ajitawi O, Chi DS. 2006. The human mast cell: an overview. Methods in Molecular Biology 315:13-34.
21. Lemay AM, Haston CK. 2008. Radiation-induced lung response of AcB/BcA recombinant congenic mice. Radiation Research 170:299-306.
22. Majori M, Poletti V, Curti A, Corradi M, Falcone F, Pesci A. 2000. Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. Journal of Allergy and Clinical Immunology 105:239-244.
23. Martin C, Romero S, Sanchez-Paya J, Massuti B, Arriero JM, Hernandez L. 1999. Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation. European Respiratory Journal 13:727-732.
24. McBride WH, Vegesna V. 2000. The role of T-cells in radiation pneumonitis after bone marrow transplantation. International Journal of Radiation Biology 76:517-521.
25. O'Brien TJ, Letuve S, Haston CK. 2005. Radiation-induced strain differences in mouse alveolar inflammatory cell apoptosis. Canadian Journal of Physiology and Pharmacology 83:117-122.
26. Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE. 2006. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Strahlentherapie und Onkologie 182:400-407.
27. Overbeek MJ, van Nieuw Amerongen GP, Boonstra A, Smit EF, Vonk-Noordegraaf A. 2008. Possible role of imatinib in clinical pulmonary veno-occlusive disease. European Respiratory Journal 32:232-235.
28. Para AE, Bezjak A, Yeung IWT, Van Dyk J, Hill RP. 2009. Effects of genistein following fractionated lung irradiation in mice. Radiotherapy and Oncology 92:500-510.
29. Paun A, Lemay A-M, Haston CK. Gene expression profiling distinguishes radiation-induced fibrosing alveolitis from alveolitis in mice., Radiation Research (in press).
30. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, Violette SM, Grant KS, Colarossi C, Formenti SC, Munger JS. 2008. Inhibition of integrin alpha (v) beta6, an activator of latent transforming growth factor-beta, prevents radiationinduced lung fibrosis. American Journal of Respiratory and Critical Care Medicine 177:82-90.
31. Rajda J, Phatak PD. 2005. Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy. American Journal of Hematology 79:80-81.
32. Roberts CM, Foulcher E, Zaunders JJ, Bryant DH, Freund J, Cairns D, Penny R, Morgan GW, Breit SN. 1993. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Annals of Internal Medicine 118:696-700.
33. Rübe CE, Wilfert F, Palm J, König J, Burdak-Rothkamm S, Liu L, Schuck A, Willich N, Rü be C. 2004. Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. Strahlentherapie und Onkologie 180:442-448.
34. Seggewiss R, Lore K, Greiner E, Magnusson MK, Price DA, Douek DC, Dunbar CE, Wiestner A. 2005. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 105:2473-2479.
35. Sennino B, Kuhnert F, Tabruyn SP, Mancuso MR, Hu-Lowe DD, Kuo CJ, McDonald DM. 2009. Cellular source and amount of vascular endothelial growth factor and plateletderived growth factor in tumors determine response to angiogenesis inhibitors. Cancer Research 69:4527-4536.
36. Sharplin J, Franko AJ. 1989a. A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiation Research 119:21-14.
37. Sharplin J, Franko AJ. 1989b. A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the intermediate and late phases. Radiation Research 119:15-31. (Pubitemid 19197733)
38. Sherbenou DW, Druker BJ. 2007. Applying the discovery of the Philadelphia chromosome. Journal of Clinical Investigation 117:2067-2074.
39. Sims JT, Ganguly S, Fiore LS, Holler CJ, Park ES, Plattner R. 2009. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner. Biochemical Pharmacology 78:249-260.
40. Sundstrom M, Vliagoftis H, Karlberg P, Butterfield JH, Nilsson K, Metcalfe DD, Nilsson G. 2003. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 108:89-97.
41. Tee PG, Travis EL. 1995. Basic fibroblast growth factor does not protect against classical radiation pneumonitis in two strains of mice. Cancer Research 55:298-302.
42. Thomson AW, Turnquist HR, Raimondi G. 2009. Immunoregulatory functions of mTOR inhibition. Nature Reviews Immunology 9:324-337.
43. Tsoutsou PG, Koukourakis MI. 2006. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. International Journal of Radiation Oncology Biology Physics 66:1281-1293.
44. Vlahovic G, Ponce AM, Rabbani Z, Salahuddin FK, Zgonjanin L, Spasojevic I, Vujaskovic Z, Dewhirst MW. 2007. Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts. British Journal of Cancer 97:735-740.
45. Williams JP, Hernady E, Johnston CJ, Reed CM, Fenton B, Okunieff P, Finkelstein JN. 2004. Effect of administration of Lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiation Research 161:560-567.